AUR-1001

N/A

Report date: 2022/09/09 20:00:42

Base Information

Drug NameAUR-1001
Drug Alias NameOX-1406
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGlycoproteins inhibitors
TargetsGlycoproteins
Therapy Area/IndicationsAntiphospholipid Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAura Biopharm AS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAura Biopharm AS
Active IndicationsN/A
Inactive IndicationsAntiphospholipid Syndrome

Other Information

ATC CodeN/A
Related LinksN/A